Your browser doesn't support javascript.
loading
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma.
de Galiza Barbosa, Felipe; Riesterer, Oliver; Tanadini-Lang, Stephanie; Stieb, Sonja; Studer, Gabriela; Pruschy, Martin; Huber, Gerhard F; Huellner, Martin W; Stolzmann, Paul; Veit-Haibach, Patrick.
Afiliação
  • de Galiza Barbosa F; Department Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
  • Riesterer O; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Stieb S; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Studer G; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Pruschy M; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Huber GF; Department of Otorhinolaryngology, Head & Neck Surgery, University Hospital Zurich, Zurich, Switzerland.
  • Huellner MW; Department Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
  • Stolzmann P; Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland.
  • Veit-Haibach P; University of Zurich, Zurich, Switzerland.
Head Neck ; 42(2): 163-170, 2020 02.
Article em En | MEDLINE | ID: mdl-31705729
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Fluordesoxiglucose F18 Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Fluordesoxiglucose F18 Idioma: En Ano de publicação: 2020 Tipo de documento: Article